Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition - Joseph L. Collura; Kuan Cheok Lei; Mitalee Chandra; Thibault Kervarrec; Hyun Jung Park; Mazdak Dalkoohi; Jürgen C. Becker; Yuan Chang; Patrick S. Moore; Masahiro Shuda (Proceedings of the National Academy of Sciences, 2025)